Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2021Cell ReportsOpen Access

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

NDNicholas C. DeVitoDuke UniversityMSMichael SturdivantUniversity of North Carolina at Chapel HillBTBalamayooran Thievanthiran

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

DeVito et al. (2021) studied this question.

synapsesocial.com/papers/6a819772b35cb7638cee1f9ehttps://doi.org/10.1016/j.celrep.2021.109071
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy2020 · 259 citations
  2. 2Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab2016 · 251 citations